All lobbying filings

WILEY REIN LLP

Lobbying for FRESENIUS KABI USA LLC · Pharmaceutical manufacturing

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

H.R.3269/S.2276, Eliminating Thickets to Increase Competition (ETHIC) Act H.R.6485/S.43, Skinny Labels, Big Savings Act Issues related to pharmaceutical manufacturing Issues related to pharmaceutical patents

Bills named in this filing 4

H.R. 3269
ETHIC Act
S. 2276
ETHIC Act
H.R. 6485
Skinny Labels, Big Savings Act
S. 43
Skinny Labels, Big Savings Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.